The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell lines
- 31 May 1992
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 45 (2) , 185-191
- https://doi.org/10.1016/0090-8258(92)90283-o
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- In vitro sensitivity assays in cancer: A review, analysis, and prognosisJournal of Clinical Laboratory Analysis, 1991
- Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescenceGynecologic Oncology, 1990
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988
- Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlationsCancer, 1984
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Ultrasensitive assay for ribonucleoside triphosphates in 50–1000 cellsBiochemical Pharmacology, 1983
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapyThe American Journal of Medicine, 1981
- Perspectives on research in gynecologic oncology.Treatment protocolsCancer, 1976
- Nonhormonal chemotherapy of endometrial adenocarcinoma: A reviewCancer, 1974